Researchers say that they have developed an HIV treatment capable of blocking infection in monkeys for more than 40 weeks after being administered. The results, reported today in Nature, appear so promising that the researchers believe it may be able to work as an effective HIV vaccine. The research was led from the Scripps Research Institute.
THE RESEARCHERS ARE EAGER TO BEGIN HUMAN TRIALS
The treatment works by injecting a subject with a harmless virus that prompts the body to create a protein of the researchers' design. That protein is then able to block parts of the virus that are used for latching onto cells, thus preventing it from spreading.